These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 20354203)
41. Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery. Campos D; Freitas D; Gomes J; Reis CA Expert Rev Proteomics; 2015 Aug; 12(4):337-42. PubMed ID: 26098314 [TBL] [Abstract][Full Text] [Related]
42. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers. Badr HA; Alsadek DM; Darwish AA; Elsayed AI; Bekmanov BO; Khussainova EM; Zhang X; Cho WC; Djansugurova LB; Li CZ Expert Rev Proteomics; 2014 Apr; 11(2):227-36. PubMed ID: 24611567 [TBL] [Abstract][Full Text] [Related]
43. Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface. Drake RR; Ball L Adv Cancer Res; 2015; 126():xiii-xiv. PubMed ID: 25727154 [No Abstract] [Full Text] [Related]
44. [Alterations of proteins and lipids glycosylation in pancreatic diseases]. Gruszewska E; Chrostek L Pol Merkur Lekarski; 2011 Jan; 30(175):52-5. PubMed ID: 21542246 [TBL] [Abstract][Full Text] [Related]
45. Acute phase glycoproteins: bystanders or participants in carcinogenesis? Dempsey E; Rudd PM Ann N Y Acad Sci; 2012 Apr; 1253():122-32. PubMed ID: 22352780 [TBL] [Abstract][Full Text] [Related]
46. Altered glycosylation in tumours focused to cancer diagnosis. Peracaula R; Barrabés S; Sarrats A; Rudd PM; de Llorens R Dis Markers; 2008; 25(4-5):207-18. PubMed ID: 19126965 [TBL] [Abstract][Full Text] [Related]
47. Altered glycosylation in prostate cancer. Drake RR; Jones EE; Powers TW; Nyalwidhe JO Adv Cancer Res; 2015; 126():345-82. PubMed ID: 25727153 [TBL] [Abstract][Full Text] [Related]
48. Glycosylation alterations in lung and brain cancer. Lemjabbar-Alaoui H; McKinney A; Yang YW; Tran VM; Phillips JJ Adv Cancer Res; 2015; 126():305-44. PubMed ID: 25727152 [TBL] [Abstract][Full Text] [Related]
50. Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN). Schmitt M; Lazar V Bioanalysis; 2010 May; 2(5):851-3. PubMed ID: 21083216 [No Abstract] [Full Text] [Related]
51. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Brooks SA; Carter TM; Royle L; Harvey DJ; Fry SA; Kinch C; Dwek RA; Rudd PM Anticancer Agents Med Chem; 2008 Jan; 8(1):2-21. PubMed ID: 18220502 [TBL] [Abstract][Full Text] [Related]
52. Glycoproteins in the Sera of Oncological Patients. Hernychová L; Uhrík L; Nenutil R; Novotný MV Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705 [TBL] [Abstract][Full Text] [Related]
53. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Kim YJ; Varki A Glycoconj J; 1997 Aug; 14(5):569-76. PubMed ID: 9298689 [No Abstract] [Full Text] [Related]
54. Protein glycosylation in cancer. Stowell SR; Ju T; Cummings RD Annu Rev Pathol; 2015; 10():473-510. PubMed ID: 25621663 [TBL] [Abstract][Full Text] [Related]
55. Glycoimmunomics of human cancer: current concepts and future perspectives. Ravindranath MH; Yesowitch P; Sumobay C; Morton DL Future Oncol; 2007 Apr; 3(2):201-14. PubMed ID: 17381420 [TBL] [Abstract][Full Text] [Related]
57. Biomarkers in public health. Srivastava S Cancer Biomark; 2011-2012; 10(1):1-2. PubMed ID: 22297546 [No Abstract] [Full Text] [Related]
58. Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies. Silva ML Biochim Biophys Acta; 2015 Dec; 1856(2):165-77. PubMed ID: 26232626 [TBL] [Abstract][Full Text] [Related]
59. Harnessing changes in cellular glycosylation in new cancer treatment strategies. Dwek MV; Brooks SA Curr Cancer Drug Targets; 2004 Aug; 4(5):425-42. PubMed ID: 15320718 [TBL] [Abstract][Full Text] [Related]
60. The cancer testis antigen PRAME as a biomarker for solid tumor cancer management. Goodison S; Urquidi V Biomark Med; 2012 Oct; 6(5):629-32. PubMed ID: 23075240 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]